Skip to content

2D Perfusion DSA for the Quantification of Infrapopliteal Angioplasty

Feasibility of 2D Perfusion DSA With Custom-made, Color-coded Software for the Quantification of Foot Perfusion Following Infrapopliteal Angioplasty

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04356092
Enrollment
7
Registered
2020-04-22
Start date
2017-05-02
Completion date
2019-07-14
Last updated
2020-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemia Limb

Keywords

Infrapopliteal angioplasty, Tissue perfusion, Quantification

Brief summary

A custom-made, 2D-perfusion digital subtraction angiography (PDSA) algorithm has been designed and implemented towards foot perfusion quantification following endovascular treatment of critical limb ischemia (CLI), in order to assist intra-procedural decision-making and enhance clinical outcomes.

Detailed description

This is a prospective, single-center, study investigating the feasibility of 2D-PDSA using newly-developed, non-commercially available, color-coded software for the quantification of foot perfusion following infrapopliteal angioplasty for the treatment of CLI. In total, 7 consecutive patients scheduled to undergo infrapopliteal endovascular treatment of CLI were enrolled. Perfusion Blood Volume (PBV), Mean Transit Time (MTT), and Perfusion Blood Flow (PBF) maps were extracted by analyzing Time-Intensity Curves and signal intensity on the perfused vessel mask. Mean values calculated from user-specified ROIs on perfusion maps were employed to evaluate the patient's pre- and post- endovascular treatment condition.

Interventions

DIAGNOSTIC_TEST2D perfusion digital subtraction angiography of the foot.

2D perfusion digital subtraction angiography of the foot was performed after infrapopliteal angioplasty and Perfusion Blood Volume (PBV), Mean Transit Time (MTT), and Perfusion Blood Flow (PBF) maps were extracted by analyzing Time-Intensity Curves and signal intensity on the perfused vessel mask.

Sponsors

University Hospital of Patras
CollaboratorOTHER
Attikon Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Masking description

2D-perfusion imaging and analysis of the DICOM files was performed after revascularization, by an investigator blinded to the name of the patient or the result of the angioplasty procedure. The participant was also blinded to the results of the perfusion outcomes during follow up.

Intervention model description

In total, 7 consecutive patients were included in the study. The 2D-perfusion imaging and analysis of the DICOM files were performed after revascularization.

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Patients prescheduled for infrapopliteal angioplasty due to chronic limb-threatening ischemia. * Written informed consent obtained

Exclusion criteria

* Image post-processing not feasible due to significant motion artifacts produced during DSA

Design outcomes

Primary

MeasureTime frameDescription
Change in Perfusion Blood Volume (PBV)Ten minutes before and five minutes after the interventionPBV calculated on subtraction images and pre- and post-procedural values were compared using the proposed 2D perfusion DSA software.
Change in Mean Transit Time (MTT)Ten minutes before and five minutes after the interventionMTT calculated on subtraction images and pre- and post-procedural values were compared using the proposed 2D perfusion DSA software.
Change in Perfusion Blood Flow (PBF)Ten minutes before and five minutes after the interventionPBF calculated on subtraction images and pre- and post-procedural values compared using the proposed 2D perfusion DSA software.

Secondary

MeasureTime frameDescription
Major amputation rateSix monthsThe rate of above the knee target limb amputation
Procedure-related complications30 daysComplications noted during and after the index procedure

Countries

Greece

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026